Immunomedics Inc (IMMU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 06-2018 | 06-2017 | 06-2016 | |
| Sales | 295 | 0 | 2,156 | 3,091 | 3,233 |
| Cost of Goods | N/A | N/A | 613 | 483 | 1,159 |
| Gross Profit | 295 | N/A | 1,543 | 2,608 | 2,074 |
| Operating Expenses | 325,133 | 0 | 143,203 | 82,241 | 61,241 |
| Operating Income | -324,838 | N/A | -141,047 | -79,150 | -59,008 |
| Interest Expense | 40,337 | 0 | 23,255 | 5,480 | 5,480 |
| Other Income | 7,856 | 0 | -109,429 | -68,616 | 298 |
| Pre-tax Income | -357,319 | 0 | -273,731 | -153,246 | -64,190 |
| Income Tax | N/A | N/A | 156 | 20 | -5,054 |
| Net Income Continuous | -357,319 | N/A | -273,887 | -153,266 | -59,136 |
| Minority Interests | -129 | N/A | -50 | -60 | -99 |
| Net Income | $-357,190 | $N/A | $-273,837 | $-153,206 | $-59,037 |
| EPS Basic Total Ops | -1.84 | N/A | -1.78 | -1.47 | -0.62 |
| EPS Basic Continuous Ops | -1.85 | N/A | -1.78 | -1.47 | -0.62 |
| EPS Diluted Total Ops | -1.84 | N/A | -1.78 | -1.47 | -0.62 |
| EPS Diluted Continuous Ops | -1.85 | N/A | -1.78 | -1.47 | -0.62 |
| EPS Diluted Before Non-Recurring Items | -1.84 | -1.03 | N/A | N/A | N/A |
| EBITDA(a) | $-320,966 | $N/A | $-137,838 | $-77,333 | $-56,771 |